Navigation Links
Inclinix Releases Next Generation Critical Population Research(R) (CPR) for Clinical Trial Investigator Site Selection and Patient Recruitment
Date:1/13/2009

WILMINGTON, N.C., Jan. 13 /PRNewswire/ -- Inclinix, Inc., a clinical trial enrollment solutions provider, announces the release of its next generation Critical Population Research(R) (CPR) system. A proprietary technology that integrates numerous public and private databases, CPR analyzes each investigator site for multiple criteria to identify the optimal sites for clinical trials. The CPR database has been expanded to include profiles on 40,000 additional investigators, now totaling over 100,000, including thousands of international investigators. This international capacity provides sponsors with a global analysis of prospective sites.

Critical Population Research identifies where patients with a specific condition are concentrated by providing color-coded maps of disease prevalence from national to ZIP code level. These maps identify clusters of sites that maximize media budgets and even provide visual insight into geographic barriers to clinical trial participation, such as availability of public transportation or parking. Inclinix's Media Optimizer uses this aspect of CPR as its foundation, implementing only the most effective and cost-efficient patient outreach for each site. This process, complemented by the extensive CPR investigator database, provides a powerful dataset for site selection and patient recruitment.

"The clinical trials industry has repeatedly identified site initiation as a primary cause of delays," explains J. Tobin Geatz, Inclinix President and CEO. "Our enhanced CPR technology offers our clients a proven, scientific solution to investigator site selection. By initiating only the most qualified investigators who have access to the right patients, trials will enroll - and ultimately complete - faster and at less cost."

In a three-year retrospective analysis of multiple trials, Inclinix found that investigators located in CPR "hot zones" (areas of high disease prevalence) enrolled at a rate nearly three times faster than those located in "cold zones" (areas of low disease prevalence). This data-driven approach to site selection results in identification of the most qualified investigators, leading to faster, more effective patient recruitment and trial completion.

About Inclinix

Inclinix, Inc. specializes in customized Phase I-IV clinical trial enrollment solutions that deliver productive investigator sites and qualified patients for the pharmaceutical, biotech and medical device industry. Clients benefit from ten years of experience in multiple therapeutic areas, as well as leading edge technologies that meet the challenge of clinical development from feasibility through compliance.

For more information, visit www.inclinix.com.


'/>"/>
SOURCE Inclinix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Inclinix Announces New Patent for Expert System Platform
2. Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials
3. Eularis Releases First-Ever Study on ROI of Pre-Launch Named Patient Programmes
4. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
5. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
6. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
7. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
8. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
9. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
10. Immunosyn Corporation Releases SF-1019 Study Results
11. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , Feb. 22, 2017   Protein Sciences Corporation ... Flublok® Influenza Vaccine , announced today that they ... Influenza Vaccine Introduction (PIVI) and the Mongolian Ministry of ... of the flu.  The doses of Flublok have been ... Mongolia for health care workers, pregnant women, ...
(Date:2/22/2017)... , Feb. 22, 2017 The Senior Care ... U.S. Senate and House of Representatives that will curtail ... Managers (PBMs) -- from extracting retroactive direct and indirect ... care (LTC) pharmacies and the Medicare program. ... (R-WV) and Jon Tester (D-MT), and ...
(Date:2/22/2017)... 22, 2017 Research and Markets has ... Market (Thermometers - Digital, Infrared, Mercury; Trend Indicator):Analysis By Region, By ... ... is forecasted to grow at a CAGR of 5.33% during 2016-2021 ... of infectious diseases along with surging demand of digital thermometer. Apart ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... VitreosHealth ... each Medicare Advantage member’s risk, identify any gaps-in-coding, as well as gaps-in-care ... transform the HCC Risk Adjustment process from a typical fragmented process to ...
(Date:2/22/2017)... ... February 22, 2017 , ... A cylindrical “pipeline” used for ... to reach ones, according to the results of a clinical trial announced Wednesday. ... by Ricardo A. Hanel, MD, PhD, neurovascular surgeon with Baptist Health and Lyerly ...
(Date:2/22/2017)... ... February 22, 2017 , ... Sideline Products participated in the World ... TV host Tom Seay and his production crew. Tom Seay’s program “Best of ... the world. Saddle Sidekicks will be featured on April 6, 2017. After the ...
(Date:2/22/2017)... ... 2017 , ... Using the power of the internet, IdrisArkette.com has managed to ... period of just 24 months, thousands of individuals interested in a medical procedure managed ... “The internet is not getting quieter. In fact it’s becoming noisier by the day. ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ANGLESTRONG , ... Angle, is now available on the App Store and Google Play ... apps for the addiction and recovery industry, partnered with Angle to build ANGLESTRONG. The ...
Breaking Medicine News(10 mins):